MSG Publications

 

  1. Sanders DB, Burns TM, Cutter GR, Massey JM, Juel VC, Hobson-Webb L; Muscle Study Group. Does Change in AChR Antibody Level Correlate with Clinical Change in MG? Musccle Nerve 2013; July 8 [Epub ahead of print]. PMID:23835683
  2. Lewis RA, McDermott MP, Herrmann DN, Hoke A, Clawson LL, Siskind C, Feeley SME, Miller LJ, Barohn RJ, Smith P, Luebbe E, Wu X, Shy ME for the Muscle Study Group. High-Dosage Ascorbic Acid Treatment in Charcot-Marie-Tooth Disease Type 1A. JAMA Neurol. 2013 Published online June 24, 2013. PMID: 23797954

  3. Pasnoor M, He J, Herbelin L, Dimachkie M, Barohn RJ and the Muscle Study Group.  Phase II Trial of Methotrexate in Myasthenia Gravis.  Annals of the New York Academy of Sciences 2012 Dec; 1275:23-8.  PMID: 23278574.

  4. Kaufmann P, McDermott MP, Darras BT, Finkel RS, Sproule DM, Kang PB, Oskoui M, Constantinescu A, Gooch CL, Foley AR, Yang ML, Tawil R, Chung WK, Martens WB, Montes J, Battista V, O'Hagen J, Dunaway S, Flickinger J, Quigley J, Riley S, Glanzman AM, Benton M, Ryan PA, Punyanitya M, Montgomery MJ, Marra J, Koo B, DiVivo DC; Muscle Study Group (MSG); Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy (PNCR). Prospective Cohort Study of Spinal Muscular Atrophy Types 2 and 3. Neurology. 2012 (Oct 30; 79(18):1889-97. PMID: 23077013.

  5. Rose MR, Sadjadi R, Weinman J, Akhtar T, Pandya S, Kissel JT, Jackson CE, Muscle Study Group. Role of disease severity, illness perceptions, and mood on quality of life in muscle disease. Muscle nerve. 2012 Sep; 46(3):351-59. PMID: 22907225
  6. Sadjadi R, Vincent KA, Carr AJ, Walburn J, Brooks VL, Pandya S, Kissel JT, Jackson CE, Rose MR and the Muscle Study Group. Validation of the individualised neuromuscular quality of life for the US with comparison of the impact of muscle disease on those living in USA versus UK. Health Qual Life Outcomes. 2011. Dec 16;9:114. PMID: 22177525.
  7. Kaufmann P, McDermott MP, Darras BT, Finkel R, Kang P, Oskoui M, Constantinescu A, Sproule DM, Foley AR, Yang M, Tawil R, Chung W, Martens B, Montes J, O'Hagen J, Dunaway S, Flickinger JM, Quigley J, Riley S, Glanzman AM, Benton M, Ryan PA, Irvine C, Annis CL, Butler H, Caracciolo J, Montgomery M, Marra J, Koo B, De Vivo D;C Muscle Study Group; Pediatric Neuromuscular Clinical Research Network for Spinal Muscular Atrophy. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol. 2011. Jun;68(6):779-86. PMID: 21320981
  8. The Muscle Study Group. A Randomized, Pilot Trial of Etanercept in Dermatomyositis. Ann Neurol. 2011. Epub 2011 Jun 17. PMID: 21688301.

  9. Sadjadi R, Rose MR; Muscle Study Group. What determines quality of life in inclusion body myositis?J Neurol Neurosurg Psychiatry. 2010 Oct;81(10):1164-6. Epub 2010 Jul 2. PMID: 20601666.

  10. Montes J, McDermott MP, Martens WB, Dunaway S, Glanzman AM, Riley S, Quigley J, Montgomery MJ, Sproule D, Tawil R, Chung WK, Darras BT, DeVivo DC, Kaufmann P, Finkel RS; Muscle Study Group and the Pediatric Neuromuscular Clinical Research Network. Six-Minute Walk Test Demonstrates Motor Fatigue in Spinal Muscular Atrophy. Neurology 2010 Mar 9;74(10):833-8. PMID: 20211907.
  11. Jackson CE, Gronseth G, Rosenfeld J, Barohn RJ, Dubinsky R, Simpson CB, McVey A, Kittrell PP, King R, Herbelin L, Muscle Study Group. Randomized double-blind study of botulinum toxin type B for sialorrhea in ALS patients. Muscle Nerve. 2009;39(2):137-43. PMID: 19145653.

  12. Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve. 2008;38(2):957-63. PMID: 18642357.
  13. Burns TM, Conaway MR, Cutter GR, Sanders DB, Muscle Study Group. Construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle Nerve. 2008;38(6):1553-62. PMID: 19016543.
  14. Jackson CE, Barohn RJ, Gronseth G, Pandya S, Herbelin L, Muscle Study Group. Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle Nerve. 2008;37(4):473-6. PMID: 18236463.
  15. Mullins LL, Carpentier MY, Paul RH, Sanders DB, Muscle Study Group. Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve. 2008;38(2):947-56. PMID: 18697209.
  16. Muscle Study Group. A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. Neurology. 2008;71(6):394-9. PMID: 18434639.
  17. Vernino S, Lindstrom J, Hopkins S, Wang Z, Low PA, Muscle Study Group. Characterization of ganglionic acetylcholine receptor autoantibodies. J Neuroimmunol. 2008;197(1):63-9. PMID: 18485491. PMC2536520.
  18. Wolfe GI, Barohn RJ, Sanders DB, McDermott MP, Muscle Study Group. Comparison of outcome measures from a trial of mycophenolate mofetil in myasthenia gravis. Muscle Nerve. 2008;38(5):1429-33. PMID: 18949779.
  19. O'Hagen JM, Glanzman AM, McDermott MP, Ryan PA, Flickinger J, Quigley J, Riley S, Sanborn E, Irvine C, Martens WB, Annis C, Tawil R, Oskoui M, Darras BT, Finkel RS, De Vivo DC. An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord. 2007;17(9-10):693-7. PMID: 17658255.
  20. Bushby K, Griggs R. 145th ENMC International Workshop: planning for an International Trial of Steroid Dosage Regimes in DMD (FOR DMD), 22-24th October 2006, Naarden, The Netherlands. Neuromuscul Disord. 2007;17(5):423-8. PMID: 17433676.
  21. Muscle Study Group. Randomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis. Neurology. 2004;63(4):718-20. PMID: 15326251.
  22. Muscle Study Group. Randomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis. Neurology. 2001;57(9):1566-70. PMID: 11706093.


Abstracts

  1. Burns TM, Conaway M, Sanders DB, Muscle Study Group. Correlation of quality-of-life with regional symptoms and signs in MG: Muscle Study Group CellCept trial experience. Ann NY Acad Sci 2008; 1132:369-370. (Abstract)
  2. Massey JM, Sanders DB, Saperstein DS, Barohn RJ, Meriggioli MN, Nations SP, Muscle Study Group. Comparison of single fiber EMG studies to outcome measures in a controlled study of mycophenolate mofetil in generalized MG. Ann NY Acad Sci 2008; 1132:377. (Abstract)